Cargando…
The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
p53 immunohistochemistry is considered an accurate surrogate marker reflecting the underlying TP53 mutation status and has utility in tumor diagnostics. In the present study, 269 primary CRCs were immunohistochemically evaluated for p53 expression to assess its utility in diagnostic pathology and pr...
Autores principales: | Nagao, Kazuhiro, Koshino, Akira, Sugimura-Nagata, Akane, Nagano, Aya, Komura, Masayuki, Ueki, Akane, Ebi, Masahide, Ogasawara, Naotaka, Tsuzuki, Toyonori, Kasai, Kenji, Takahashi, Satoru, Kasugai, Kunio, Inaguma, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948732/ https://www.ncbi.nlm.nih.gov/pubmed/35328677 http://dx.doi.org/10.3390/ijms23063252 |
Ejemplares similares
-
SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer
por: Sugimura-Nagata, Akane, et al.
Publicado: (2022) -
Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer
por: Ueki, Akane, et al.
Publicado: (2023) -
PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer
por: Koshino, Akira, et al.
Publicado: (2022) -
Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
por: Sugimura-Nagata, Akane, et al.
Publicado: (2021) -
Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer
por: Inoue, Satoshi, et al.
Publicado: (2020)